BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chioncel O, Parissis J, Mebazaa A, Thiele H, Desch S, Bauersachs J, Harjola V, Antohi E, Arrigo M, Gal TB, Celutkiene J, Collins SP, Debacker D, Iliescu VA, Jankowska E, Jaarsma T, Keramida K, Lainscak M, Lund LH, Lyon AR, Masip J, Metra M, Miro O, Mortara A, Mueller C, Mullens W, Nikolaou M, Piepoli M, Price S, Rosano G, Vieillard‐baron A, Weinstein JM, Anker SD, Filippatos G, Ruschitzka F, Coats AJ, Seferovic P. Epidemiology, pathophysiology and contemporary management of cardiogenic shock – a position statement from the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 2020;22:1315-41. [DOI: 10.1002/ejhf.1922] [Cited by in Crossref: 108] [Cited by in F6Publishing: 114] [Article Influence: 36.0] [Reference Citation Analysis]
Number Citing Articles
1 Khariton Y, Hassan OA, Hernandez-Montfort JA. Update on cardiogenic shock: from detection to team management. Curr Opin Cardiol 2023;38:108-15. [PMID: 36718620 DOI: 10.1097/HCO.0000000000001017] [Reference Citation Analysis]
2 Schrage B, Sundermeyer J, Blankenberg S, Colson P, Eckner D, Eden M, Eitel I, Frank D, Frey N, Graf T, Kirchhof P, Kupka D, Landmesser U, Linke A, Majunke N, Mangner N, Maniuc O, Mierke J, Möbius-Winkler S, Morrow DA, Mourad M, Nordbeck P, Orban M, Pappalardo F, Patel SM, Pauschinger M, Pazzanese V, Radakovic D, Schulze PC, Scherer C, Schwinger RHG, Skurk C, Thiele H, Varshney A, Wechsler L, Westermann D. Timing of Active Left Ventricular Unloading in Patients on Venoarterial Extracorporeal Membrane Oxygenation Therapy. JACC Heart Fail 2023;11:321-30. [PMID: 36724180 DOI: 10.1016/j.jchf.2022.11.005] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Pahuja M, Yerasi C, Lam PH, Hashim H, Ben-Dor I, Bernardo NL, Satler LF, Sheikh FH, Najjar SS, Molina EJ, Waksman R. Review of Pathophysiology of Cardiogenic Shock and Escalation of Mechanical Circulatory Support Devices. Curr Cardiol Rep 2023. [PMID: 36847990 DOI: 10.1007/s11886-023-01843-4] [Reference Citation Analysis]
4 Novosadov MM, Novosadov VM, Dzhioeva ON, Drapkina OM. Practical aspects of managing patients with cardiogenic shock. Russ J Cardiol 2023;28:5337. [DOI: 10.15829/1560-4071-2023-5337] [Reference Citation Analysis]
5 Randhawa VK, Sinha SS, Hernandez-Montfort J. An Evolving Roadmap for Cardiogenic Shock Requiring Temporary Mechanical Circulatory Support. JACC Asia 2023;3:135-7. [PMID: 36873756 DOI: 10.1016/j.jacasi.2022.11.010] [Reference Citation Analysis]
6 Kondo T, Araki T, Imaizumi T, Sumita Y, Nakai M, Tanaka A, Okumura T, Butt JH, Petrie MC, McMurray JJV, Murohara T. Prognosis in Patients With Cardiogenic Shock Who Received Temporary Mechanical Circulatory Support. JACC Asia 2023;3:122-34. [PMID: 36873766 DOI: 10.1016/j.jacasi.2022.10.004] [Reference Citation Analysis]
7 Falco L, Martucci ML, Valente F, Verrengia M, Pacileo G, Masarone D. Pathophysiology-Based Management of Acute Heart Failure. Clin Pract 2023;13:206-18. [PMID: 36826161 DOI: 10.3390/clinpract13010019] [Reference Citation Analysis]
8 Barnett CF, Brusca SB, Hanff TC, Blumer V, Kaliff A, Kanwar M. Management of Cardiogenic Shock Unrelated to Acute Myocardial Infarction. Can J Cardiol 2023:S0828-282X(23)00069-7. [PMID: 36731605 DOI: 10.1016/j.cjca.2023.01.023] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Copeland VJ, Fardman A, Furer A. Keep the Right in Mind-A Focused Approach to Right Ventricle-Predominant Cardiogenic Shock. Life (Basel) 2023;13. [PMID: 36836735 DOI: 10.3390/life13020379] [Reference Citation Analysis]
10 Moreau A, Levy B, Annoni F, Lorusso R, Su F, Belliato M, Taccone FS. The use of induced hypothermia in extracorporeal membrane oxygenation: A narrative review. Resusc Plus 2023;13:100360. [PMID: 36793940 DOI: 10.1016/j.resplu.2023.100360] [Reference Citation Analysis]
11 Couture EJ, Laferrière-Langlois P, Denault A. New Developments in Continuous Hemodynamic Monitoring of the Critically Ill Patient. Can J Cardiol 2023:S0828-282X(23)00049-1. [PMID: 36669685 DOI: 10.1016/j.cjca.2023.01.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Jiang Y, Zhu Y, Xiang Z, Sasmita BR, Wang Y, Ming G, Chen S, Luo S, Huang B. The prognostic value of admission D-dimer level in patients with cardiogenic shock after acute myocardial infarction. Front Cardiovasc Med 2022;9:1083881. [PMID: 36698952 DOI: 10.3389/fcvm.2022.1083881] [Reference Citation Analysis]
13 Regoli FD, Cattaneo M, Kola F, Thartori A, Bytyci H, Saccarello L, Amoruso M, Di Valentino M, Menafoglio A. Management of hemodynamically stable wide QRS complex tachycardia in patients with implantable cardioverter defibrillators. Front Cardiovasc Med 2022;9:1011619. [PMID: 36684577 DOI: 10.3389/fcvm.2022.1011619] [Reference Citation Analysis]
14 Ruben M, Molinas MS, Paladini H, Khalife W, Barbagelata A, Perrone S, Kaplinsky E. Emerging concepts in heart failure management and treatment: focus on point-of-care ultrasound in cardiogenic shock. Drugs Context 2023;12. [PMID: 36660015 DOI: 10.7573/dic.2022-5-8] [Reference Citation Analysis]
15 Varshney AS, Berg DD, Zhou G, Sinnenberg L, Hirji S, DeFilippis EM, Mallidi HR, Morrow DA, Rinewalt D, Givertz MM. Bridging strategies and cardiac replacement outcomes in patients with acute decompensated heart failure-related cardiogenic shock. Eur J Heart Fail 2023. [PMID: 36597721 DOI: 10.1002/ejhf.2762] [Reference Citation Analysis]
16 Sangalli F, Mariani S, Fumagalli R. Extracorporeal Life Support (ECLS) for Critically Ill Patients in the Emergency Department. The High-risk Surgical Patient 2023. [DOI: 10.1007/978-3-031-17273-1_31] [Reference Citation Analysis]
17 Barrionuevo-Sánchez MI, Ariza-Solé A, Prado ND, García M, Sánchez-Salado JC, Lorente V, Alegre O, Llaó I, Bernal JL, Fernández-Pérez C, Galván-Román F, Cuerda F, Pascual J, Cequier A, Comin-Colet J, Elola FJ. Impact of shock aetiology and hospital characteristics on the clinical profile, management and prognosis of patients with non ACS-related cardiogenic shock. Hellenic J Cardiol 2023;69:16-23. [PMID: 36334704 DOI: 10.1016/j.hjc.2022.11.001] [Reference Citation Analysis]
18 Lescroart M, Pequignot B, Janah D, Levy B. The medical treatment of cardiogenic shock. Journal of Intensive Medicine 2023. [DOI: 10.1016/j.jointm.2022.12.001] [Reference Citation Analysis]
19 Nogi K, Ueda T, Nakamura T, Nogi M, Ishihara S, Nakada Y, Hashimoto Y, Nakagawa H, Nishida T, Seno A, Onoue K, Watanabe M, Saito Y. New Classification for the Combined Assessment of the Fractional Excretion of Urea Nitrogen and Estimated Plasma Volume Status in Acute Heart Failure. J Am Heart Assoc 2023;12:e025596. [PMID: 36583422 DOI: 10.1161/JAHA.122.025596] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Tomii D, Pilgrim T, Windecker S. Emergency transcatheter aortic valve implantation: expanding indication and concern of delayed treatment of aortic stenosis. Eur Heart J Acute Cardiovasc Care 2022;11:887-90. [PMID: 36345728 DOI: 10.1093/ehjacc/zuac142] [Reference Citation Analysis]
21 Steffen J, Stocker A, Scherer C, Haum M, Fischer J, Doldi PM, Theiss H, Braun D, Rizas K, Peterß S, Hausleiter J, Massberg S, Orban M, Deseive S. Emergency transcatheter aortic valve implantation for acute heart failure due to severe aortic stenosis in critically ill patients with or without cardiogenic shock. Eur Heart J Acute Cardiovasc Care 2022;11:877-86. [PMID: 36210517 DOI: 10.1093/ehjacc/zuac131] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Colombo CNJ, Dammassa V, Klersy C, Camporotondo R, Pellegrini C, Mojoli F, Tavazzi G. Heart rate control and haemodynamic improvement with ivabradine in cardiogenic shock patient on mechanical circulatory support. Eur Heart J Acute Cardiovasc Care 2022;11:916-21. [PMID: 36222185 DOI: 10.1093/ehjacc/zuac133] [Reference Citation Analysis]
23 Riccardi M, Sammartino AM, Piepoli M, Adamo M, Pagnesi M, Rosano G, Metra M, von Haehling S, Tomasoni D. Heart failure: an update from the last years and a look at the near future. ESC Heart Fail 2022;9:3667-93. [PMID: 36546712 DOI: 10.1002/ehf2.14257] [Reference Citation Analysis]
24 Martínez-Sellés M, Hernández-Pérez FJ, Uribarri A, Martín Villén L, Zapata L, Alonso JJ, Amat-Santos IJ, Ariza-Solé A, Barrabés JA, Barrio JM, Canteli Á, Alonso-Fernández-Gatta M, Corbí Pascual MJ, Díaz D, Crespo-Leiro MG, de la Torre-Hernández JM, Ferrera C, García González MJ, García-Carreño J, García-Guereta L, García Quintana A, Jorge Pérez P, González-Juanatey JR, López de Sá E, Sánchez PL, Monteagudo M, Palomo López N, Reyes G, Rosell F, Solla Buceta MA, Segovia-Cubero J, Sionis Green A, Stepanenko A, Iglesias Álvarez D, Viana Tejedor A, Voces R, Fuset Cabanes MP, Gimeno Costa JR, Díaz J, Fernández-Avilés F. Cardiogenic shock code 2023. Expert document for a multidisciplinary organization that allows quality care. Rev Esp Cardiol (Engl Ed) 2022:S1885-5857(22)00330-9. [PMID: 36565750 DOI: 10.1016/j.rec.2022.10.014] [Reference Citation Analysis]
25 Pastore MC, Ilardi F, Stefanini A, Mandoli GE, Palermi S, Bandera F, Benfari G, Esposito R, Lisi M, Pasquini A, Santoro C, Valente S, D'Andrea A, Cameli M; Working Group of Echocardiography of the Italian Society of Cardiology. Bedside Ultrasound for Hemodynamic Monitoring in Cardiac Intensive Care Unit. J Clin Med 2022;11. [PMID: 36556154 DOI: 10.3390/jcm11247538] [Reference Citation Analysis]
26 Sanhueza S, Vergara I, Bittner A, Paredes A, Garrido L, Besa S, Castillo J, Acevedo M. Cardiogenic shock due to arrhythmia-induced cardiomyopathy and its recovery after radiofrequency ablation under extracorporeal membrane oxygenation support. Heart Rhythm O2 2022;3:874-8. [PMID: 36588999 DOI: 10.1016/j.hroo.2022.10.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Luedike P, Papathanasiou M, Schmack B, Kamler M, Perings C, Ruhparwar A, Rassaf T. Structural components for the development of a heart failure network. ESC Heart Failure 2022. [DOI: 10.1002/ehf2.14266] [Reference Citation Analysis]
28 Behnoush AH, Khalaji A, Naderi N, Ashraf H, von Haehling S. ACC/AHA/HFSA 2022 and ESC 2021 guidelines on heart failure comparison. ESC Heart Failure 2022. [DOI: 10.1002/ehf2.14255] [Reference Citation Analysis]
29 Hamzaoui O, Boissier F. Hemodynamic monitoring in cardiogenic shock. Journal of Intensive Medicine 2022. [DOI: 10.1016/j.jointm.2022.10.003] [Reference Citation Analysis]
30 Bruno RR, Wolff G, Kelm M, Jung C. Pharmacological treatment of cardiogenic shock - A state of the art review. Pharmacol Ther 2022;240:108230. [PMID: 35697151 DOI: 10.1016/j.pharmthera.2022.108230] [Reference Citation Analysis]
31 Pedicino D, Liuzzo G. Mind the map: a multi-omic approach to post-ischaemic cardiac remodelling paves the way for future cardiovascular research. Eur Heart J 2022;43:4677-8. [PMID: 36214046 DOI: 10.1093/eurheartj/ehac525] [Reference Citation Analysis]
32 Luo J, Chen D, Tang L, Deng H, Zhang C, Chen S, Chang T, Dong L, Wang W, Xu H, He M, Wan D, Yin G, Wu M, Cao F, Liu Y, Tang ZH. Multifactorial Shock: A Neglected Situation in Polytrauma Patients. J Clin Med 2022;11. [PMID: 36431304 DOI: 10.3390/jcm11226829] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 Schurtz G, Delmas C, Fenouillet M, Roubille F, Puymirat E, Bonello L, Leurent G, Verdier B, Levy B, Ternacle J, Harbaoui B, Vanzetto G, Combaret N, Lattuca B, Bruel C, Bourenne J, Labbé V, Henry P, Bonnefoy-Cudraz É, Lamblin N, Lemesle G. Impact of Pre-Existing History of Heart Failure on Patient Profile, Therapeutic Management, and Prognosis in Cardiogenic Shock: Insights from the FRENSHOCK Registry. Life (Basel) 2022;12. [PMID: 36430979 DOI: 10.3390/life12111844] [Reference Citation Analysis]
34 Na SJ, Yang JH, Ko RE, Chung CR, Cho YH, Choi KH, Kim D, Park TK, Lee JM, Song YB, Choi JO, Hahn JY, Choi SH, Gwon HC. Dopamine versus norepinephrine as the first-line vasopressor in the treatment of cardiogenic shock. PLoS One 2022;17:e0277087. [PMID: 36327286 DOI: 10.1371/journal.pone.0277087] [Reference Citation Analysis]
35 Eftychiou S, Kalakoutas A, Proudfoot A. The role of temporary mechanical circulatory support in de novo heart failure syndromes with cardiogenic shock: A contemporary review. Journal of Intensive Medicine 2022. [DOI: 10.1016/j.jointm.2022.10.002] [Reference Citation Analysis]
36 Martínez-sellés M, Hernández-pérez FJ, Uribarri A, Martín Villén L, Zapata L, Alonso JJ, Amat-santos IJ, Ariza-solé A, Barrabés JA, Barrio JM, Canteli Á, Alonso-fernández-gatta M, Corbí Pascual MJ, Díaz D, Crespo-leiro MG, de la Torre-hernández JM, Ferrera C, García González MJ, García-carreño J, García-guereta L, García Quintana A, Jorge Pérez P, González-juanatey JR, López de Sá E, Sánchez PL, Monteagudo M, Palomo López N, Reyes G, Rosell F, Solla Buceta MA, Segovia-cubero J, Sionis Green A, Stepanenko A, Iglesias Álvarez D, Viana Tejedor A, Voces R, Fuset Cabanes MP, Gimeno Costa JR, Díaz J, Fernández-avilés F. Código shock cardiogénico 2023. Documento de expertos para una organización multidisciplinaria que permita una atención de calidad. Revista Española de Cardiología 2022. [DOI: 10.1016/j.recesp.2022.10.010] [Reference Citation Analysis]
37 Belletti A, Azzolini ML, Baldetti L, Landoni G, Franco A, Zangrillo A. Inotropes and Vasopressors Use in Critical Care and Perioperative Medicine: Evidence-Based Approach (Review). Obŝaâ reanimatologiâ 2022;18:60-77. [DOI: 10.15360/1813-9779-2022-5-60-77] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
38 Luo C, Chen F, Liu L, Ge Z, Feng C, Chen Y. Impact of diabetes on outcomes of cardiogenic shock: A systematic review and meta-analysis. Diab Vasc Dis Res 2022;19:14791641221132242. [PMID: 36250870 DOI: 10.1177/14791641221132242] [Reference Citation Analysis]
39 Burgos LM, Baro Vila RC, Botto F, Diez M. SCAI Cardiogenic Shock Classification for Predicting In-Hospital and Long-Term Mortality in Acute Heart Failure. Journal of the Society for Cardiovascular Angiography & Interventions 2022. [DOI: 10.1016/j.jscai.2022.100496] [Reference Citation Analysis]
40 Tomasoni D, Adamo M, Metra M. October 2022 at a glance: focus on clinical trials. European J of Heart Fail 2022;24:1741-1743. [DOI: 10.1002/ejhf.2240] [Reference Citation Analysis]
41 Kuroda T, Miyagi C, Fukamachi K, Karimov JH. Mechanical circulatory support devices and treatment strategies for right heart failure. Front Cardiovasc Med 2022;9. [DOI: 10.3389/fcvm.2022.951234] [Reference Citation Analysis]
42 Palazzuoli A, Metra M, Collins SP, Adamo M, Ambrosy AP, Antohi LE, Ben Gal T, Farmakis D, Gustafsson F, Hill L, Lopatin Y, Tramonte F, Lyon A, Masip J, Miro O, Moura B, Mullens W, Radu RI, Abdelhamid M, Anker S, Chioncel O. Heart failure during the COVID-19 pandemic: clinical, diagnostic, management, and organizational dilemmas. ESC Heart Fail 2022;9:3713-36. [PMID: 36111511 DOI: 10.1002/ehf2.14118] [Reference Citation Analysis]
43 Sacco A, Morici N, Oreglia JA, Tavazzi G, Villanova L, Colombo C, Garatti L, Mondino MG, Nava S, Pappalardo F. Left Ventricular Unloading in Acute on Chronic Heart Failure: From Statements to Clinical Practice. JPM 2022;12:1463. [DOI: 10.3390/jpm12091463] [Reference Citation Analysis]
44 Rosano GMC, Metra M, Volterrani M. The strategic vision of the 2022-2024 mandate - greater involvement of members, young specialists for an HFA community without borders. Eur J Heart Fail 2022;24:1458-9. [PMID: 36210180 DOI: 10.1002/ejhf.2702] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
45 Tomasoni D, Adamo M, Metra M. September 2022 at a glance. European J of Heart Fail 2022;24:1455-1457. [DOI: 10.1002/ejhf.2238] [Reference Citation Analysis]
46 Delmas C, Vallee L, Bouisset F, Porterie J, Biendel C, Lairez O, Crognier L, Marcheix B, Conil JM, Maury P, Minville V. Use of Percutaneous Atrioseptotosmy for Left Heart Decompression During Veno-Arterial Extracorporeal Membrane Oxygenation Support: An Observational Study. J Am Heart Assoc 2022;:e024642. [PMID: 36000436 DOI: 10.1161/JAHA.121.024642] [Reference Citation Analysis]
47 Baldetti L, Pagnesi M, Gallone G, Barone G, Fierro N, Calvo F, Gramegna M, Pazzanese V, Venuti A, Sacchi S, De Ferrari GM, Burkhoff D, Lim HS, Cappelletti AM. Prognostic value of right atrial pressure-corrected cardiac power index in cardiogenic shock. ESC Heart Fail 2022;9:3920-30. [PMID: 35950538 DOI: 10.1002/ehf2.14093] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
48 Olarte N, Rivera NT, Grazette L. Evolving Presentation of Cardiogenic Shock: A Review of the Medical Literature and Current Practices. Cardiol Ther. [DOI: 10.1007/s40119-022-00274-6] [Reference Citation Analysis]
49 Balthazar T, Bennett J, Adriaenssens T. Hemolysis during short-term mechanical circulatory support: from pathophysiology to diagnosis and treatment. Expert Rev Med Devices 2022. [PMID: 35912874 DOI: 10.1080/17434440.2022.2108319] [Reference Citation Analysis]
50 Steinacher E, Hofer F, Kazem N, Hammer A, Koller L, Lang I, Hengstenberg C, Niessner A, Sulzgruber P. Cardiogenic Shock Does Not Portend Poor Long-Term Survival in Patients Undergoing Primary Percutaneous Coronary Intervention. JPM 2022;12:1193. [DOI: 10.3390/jpm12081193] [Reference Citation Analysis]
51 Rosano GM, Seferovic P, Savarese G, Spoletini I, Lopatin Y, Gustafsson F, Bayes‐genis A, Jaarsma T, Abdelhamid M, Miqueo AG, Piepoli M, Tocchetti CG, Ristić AD, Jankowska E, Moura B, Hill L, Filippatos G, Metra M, Milicic D, Thum T, Chioncel O, Gal TB, Lund LH, Farmakis D, Mullens W, Adamopoulos S, Bohm M, Norhammar A, Bollmann A, Banerjee A, Maggioni AP, Voors A, Solal AC, Coats AJ. Impact analysis of heart failure across European countries: an ESC‐HFA position paper. ESC Heart Failure. [DOI: 10.1002/ehf2.14076] [Reference Citation Analysis]
52 Krittanawong C, Rivera MR, Shaikh P, Kumar A, May A, Mahtta D, Jentzer J, Civitello A, Katz J, Naidu SS, Cohen MG, Menon V. SKey Concepts Surrounding Cardiogenic Shock. Curr Probl Cardiol 2022;:101303. [PMID: 35787427 DOI: 10.1016/j.cpcardiol.2022.101303] [Reference Citation Analysis]
53 Adams A, Olesky CL, Fisher A, Justice SB. Acute Heart Failure. Adv Emerg Nurs J 2022;44:178-89. [PMID: 35900236 DOI: 10.1097/TME.0000000000000414] [Reference Citation Analysis]
54 Murad CM, Mangini S. Use of Intra-Aortic Balloon Pump in Cardiogenic Shock Associated with Advanced Heart Failure: An Outdated Strategy? ABC: Heart Failure & Cardiomyopathy 2022;2:206-208. [DOI: 10.36660/abchf.20220033] [Reference Citation Analysis]
55 Kosyakovsky LB, Marbach JA, Nguyen K, Mukundan S, Chweich H, Kapur NK. Outcomes in cardiogenic shock: the role of surrogate endpoints. Curr Opin Crit Care 2022. [PMID: 35757956 DOI: 10.1097/MCC.0000000000000963] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
56 Sun D, Wei C, Li Z. Blood urea nitrogen to creatinine ratio is associated with in-hospital mortality among critically ill patients with cardiogenic shock. BMC Cardiovasc Disord 2022;22:258. [PMID: 35676647 DOI: 10.1186/s12872-022-02692-9] [Reference Citation Analysis]
57 Pérez Vela J, Llanos Jorge C, Duerto Álvarez J, Jiménez Rivera J. Clinical management of postcardiotomy shock in adults. Medicina Intensiva (English Edition) 2022;46:312-325. [DOI: 10.1016/j.medine.2022.04.014] [Reference Citation Analysis]
58 Panuccio G, Neri G, Macrì LM, Salerno N, De Rosa S, Torella D. Use of Impella device in cardiogenic shock and its clinical outcomes: A systematic review and meta-analysis. Int J Cardiol Heart Vasc 2022;40:101007. [PMID: 35360892 DOI: 10.1016/j.ijcha.2022.101007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
59 Krause TT, Rieth AJ. Aktuelle Klassifikation und hämodynamisches Profil bei kardiogenem Schock. Z Herz- Thorax- Gefäßchir 2022;36:158-163. [DOI: 10.1007/s00398-022-00507-9] [Reference Citation Analysis]
60 Rosseel T, Santens B, Droogne W, Voros G, Van Cleemput J, Van Aelst L, Budts W, Jacobs S, Van De Bruaene A, Meyns B. Ventricular assist device implantation in adults with a systemic right ventricle - A single center experience and review of the literature. International Journal of Cardiology Congenital Heart Disease 2022;8:100365. [DOI: 10.1016/j.ijcchd.2022.100365] [Reference Citation Analysis]
61 Ostrominski JW, Vaduganathan M. Evolving therapeutic strategies for patients hospitalized with new or worsening heart failure across the spectrum of left ventricular ejection fraction. Clin Cardiol 2022;45 Suppl 1:S40-51. [PMID: 35789014 DOI: 10.1002/clc.23849] [Reference Citation Analysis]
62 Jasińska-Gniadzik K, Szwed P, Gasecka A, Zawadka M, Grabowski M, Pietrasik A. Haemodynamic monitoring in acute heart failure - what you need to know. Postepy Kardiol Interwencyjnej 2022;18:90-100. [PMID: 36051835 DOI: 10.5114/aic.2022.118524] [Reference Citation Analysis]
63 Couture EJ, Grønlykke L, Denault AY. New developments in the understanding of right ventricular function in acute care. Curr Opin Crit Care 2022;28:331-9. [PMID: 35653255 DOI: 10.1097/MCC.0000000000000946] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
64 Luntungan M, Juzar D, Budiono D. Neutrophil-Albumin Ratio as a Predictor of in-Hospital Mortality in Patients with Cardiogenic Shock. Open Access Maced J Med Sci 2022;10:1731-1735. [DOI: 10.3889/oamjms.2022.8845] [Reference Citation Analysis]
65 Tomasoni D, Adamo M, Metra M. April 2022 at a glance: focus on prevention, acute heart failure and heart failure with preserved ejection fraction. Eur J Heart Fail 2022;24:593-5. [PMID: 35545950 DOI: 10.1002/ejhf.2228] [Reference Citation Analysis]
66 Jentzer JC, Schrage B, Patel PC, Kashani KB, Barsness GW, Holmes DR, Blankenberg S, Kirchhof P, Westermann D. Association Between the Acidemia, Lactic Acidosis, and Shock Severity With Outcomes in Patients With Cardiogenic Shock. JAHA. [DOI: 10.1161/jaha.121.024932] [Reference Citation Analysis]
67 Blumer V, Marbach J, Veasey T, Kanwar M. Role of medical management of cardiogenic shock in the era of mechanical circulatory support. Curr Opin Cardiol 2022;37:250-60. [PMID: 35612937 DOI: 10.1097/HCO.0000000000000966] [Reference Citation Analysis]
68 Narayan S, Petersen TL. Uncommon Etiologies of Shock. Critical Care Clinics 2022;38:429-41. [DOI: 10.1016/j.ccc.2021.11.009] [Reference Citation Analysis]
69 Mcdonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, Burri H, Butler J, Čelutkienė J, Chioncel O, Cleland JG, Coats AJ, Crespo-leiro MG, Farmakis D, Gilard M, Heyman S, Hoes AW, Jaarsma T, Jankowska EA, Lainscak M, Lam CS, Lyon AR, Mcmurray JJ, Mebazaa A, Mindham R, Muneretto C, Francesco Piepoli M, Price S, Rosano GM, Ruschitzka F, Skibelund AK. Guía ESC 2021 sobre el diagnóstico y tratamiento de la insuficiencia cardiaca aguda y crónica. Revista Española de Cardiología 2022. [DOI: 10.1016/j.recesp.2021.11.027] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
70 Jiang Y, Boris AF, Zhu Y, Gan H, Hu X, Xue Y, Xiang Z, Sasmita BR, Liu G, Luo S, Huang B. Incidence, Clinical Characteristics and Short-Term Prognosis in Patients With Cardiogenic Shock and Various Left Ventricular Ejection Fractions After Acute Myocardial Infarction. Am J Cardiol 2022;167:20-6. [PMID: 34986988 DOI: 10.1016/j.amjcard.2021.11.040] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
71 Karakas M, Akin I, Burdelski C, Clemmensen P, Grahn H, Jarczak D, Keßler M, Kirchhof P, Landmesser U, Lezius S, Lindner D, Mebazaa A, Nierhaus A, Ocak A, Rottbauer W, Sinning C, Skurk C, Söffker G, Westermann D, Zapf A, Zengin E, Zeller T, Kluge S. Single-dose of adrecizumab versus placebo in acute cardiogenic shock (ACCOST-HH): an investigator-initiated, randomised, double-blinded, placebo-controlled, multicentre trial. The Lancet Respiratory Medicine 2022;10:247-54. [DOI: 10.1016/s2213-2600(21)00439-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
72 Voizeux P, Guinot PG. Prise en charge du choc cardiogénique. Anesthésie & Réanimation 2022;8:171-179. [DOI: 10.1016/j.anrea.2022.01.011] [Reference Citation Analysis]
73 Delmas C, Pernot M, Le Guyader A, Joret R, Roze S, Lebreton G. Budget Impact Analysis of Impella CP® Utilization in the Management of Cardiogenic Shock in France: A Health Economic Analysis. Adv Ther 2022;39:1293-309. [PMID: 35067868 DOI: 10.1007/s12325-022-02040-5] [Reference Citation Analysis]
74 Iborra-egea O, García-garcía C, Bayés-genís A. Commentary: A Review of Prognosis Model Associated With Cardiogenic Shock After Acute Myocardial Infarction. Front Cardiovasc Med 2022;9. [DOI: 10.3389/fcvm.2022.856592] [Reference Citation Analysis]
75 Archilletti F, Giuliani L, Dangas GD, Ricci F, Benedetto U, Radico F, Gallina S, Rossi S, Maddestra N, Zimarino M. Timing of mechanical circulatory support during primary angioplasty in acute myocardial infarction and cardiogenic shock: Systematic review and meta-analysis. Catheter Cardiovasc Interv 2022. [PMID: 35182020 DOI: 10.1002/ccd.30137] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
76 Delmas C, Porterie J, Jourdan G, Lezoualc'h F, Arnaud R, Brun S, Cavalerie H, Blanc G, Marcheix B, Lairez O, Verwaerde P, Mialet-perez J. Effectiveness and Safety of a Prolonged Hemodynamic Support by the IVAC2L System in Healthy and Cardiogenic Shock Pigs. Front Cardiovasc Med 2022;9. [DOI: 10.3389/fcvm.2022.809143] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
77 Masip J, Frank Peacok W, Arrigo M, Rossello X, Platz E, Cullen L, Mebazaa A, Price S, Bueno H, Di Somma S, Tavares M, Cowie MR, Maisel A, Mueller C, Miró Ò; Acute Heart Failure Study Group of the Association for Acute Cardiovascular Care (ACVC) of the European Society of Cardiology. Acute Heart Failure in the 2021 ESC Heart Failure Guidelines: a scientific statement from the Association for Acute CardioVascular Care (ACVC) of the European Society of Cardiology. Eur Heart J Acute Cardiovasc Care 2022;11:173-85. [PMID: 35040931 DOI: 10.1093/ehjacc/zuab122] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
78 Jentzer JC, Bhat AG, Patlolla SH, Sinha SS, Miller PE, Lawler PR, van Diepen S, Khanna AK, Zhao DX, Vallabhajosyula S. Concomitant Sepsis Diagnoses in Acute Myocardial Infarction-Cardiogenic Shock: 15-Year National Temporal Trends, Management, and Outcomes. Critical Care Explorations 2022;4:e0637. [DOI: 10.1097/cce.0000000000000637] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
79 McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, Burri H, Butler J, Čelutkienė J, Chioncel O, Cleland JGF, Coats AJS, Crespo-Leiro MG, Farmakis D, Gilard M, Heymans S, Hoes AW, Jaarsma T, Jankowska EA, Lainscak M, Lam CSP, Lyon AR, McMurray JJV, Mebazaa A, Mindham R, Muneretto C, Francesco Piepoli M, Price S, Rosano GMC, Ruschitzka F, Kathrine Skibelund A; Authors/Task Force Members:., ESC Scientific Document Group. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). With the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 2022;24:4-131. [PMID: 35083827 DOI: 10.1002/ejhf.2333] [Cited by in Crossref: 205] [Cited by in F6Publishing: 193] [Article Influence: 205.0] [Reference Citation Analysis]
80 Tomasoni D, Adamo M, Metra M. January 2022 at a glance: time for the new ESC guidelines on heart failure. Eur J Heart Fail 2022;24:1-3. [PMID: 35083828 DOI: 10.1002/ejhf.2222] [Reference Citation Analysis]
81 Zangrillo A, Lomivorotov VV, Pasyuga VV, Belletti A, Gazivoda G, Monaco F, Nigro Neto C, Likhvantsev VV, Bradic N, Lozovskiy A, Lei C, Bukamal NAR, Silva FS, Bautin AE, Ma J, Yong CY, Carollo C, Kunstyr J, Wang CY, Grigoryev EV, Riha H, Wang C, El-Tahan MR, Scandroglio AM, Mansor M, Lembo R, Ponomarev DN, Bezerra FJL, Ruggeri L, Chernyavskiy AM, Xu J, Tarasov DG, Navalesi P, Yavorovskiy A, Bove T, Kuzovlev A, Hajjar LA, Landoni G; MYRIAD Study Group. Effect of Volatile Anesthetics on Myocardial Infarction After Coronary Artery Surgery: A Post Hoc Analysis of a Randomized Trial. J Cardiothorac Vasc Anesth 2022:S1053-0770(22)00001-5. [PMID: 35168907 DOI: 10.1053/j.jvca.2022.01.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
82 Bazmpani MA, Papanastasiou CA, Kamperidis V, Zebekakis PE, Karvounis H, Kalogeropoulos AP, Karamitsos TD. Contemporary Data on the Status and Medical Management of Acute Heart Failure. Curr Cardiol Rep 2022;24:2009-22. [PMID: 36385324 DOI: 10.1007/s11886-022-01822-1] [Reference Citation Analysis]
83 Proudfoot A, Salam AT, Hunter E. Pulmonary Embolism Causing Severe Organ Failure. Encyclopedia of Respiratory Medicine 2022. [DOI: 10.1016/b978-0-08-102723-3.00232-8] [Reference Citation Analysis]
84 Lassus J, Tarvasmäki T, Tolppanen H. Biomarkers in cardiogenic shock. Advances in Clinical Chemistry 2022. [DOI: 10.1016/bs.acc.2022.03.002] [Reference Citation Analysis]
85 Räpple D. ECLS im kardiogenen Schock. ECMO 2022. [DOI: 10.1007/978-3-662-66677-7_5] [Reference Citation Analysis]
86 Delmas C, Roubille F, Lamblin N, Bonello L, Leurent G, Levy B, Elbaz M, Danchin N, Champion S, Lim P, Schneider F, Cariou A, Khachab H, Bourenne J, Seronde MF, Schurtz G, Harbaoui B, Vanzetto G, Quentin C, Delabranche X, Aissaoui N, Combaret N, Manzo-Silberman S, Tomasevic D, Marchandot B, Lattuca B, Henry P, Gerbaud E, Bonnefoy E, Puymirat E. Baseline characteristics, management, and predictors of early mortality in cardiogenic shock: insights from the FRENSHOCK registry. ESC Heart Fail 2021. [PMID: 34973047 DOI: 10.1002/ehf2.13734] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
87 Stretti L, Zippo D, Coats AJS, Anker MS, von Haehling S, Metra M, Tomasoni D. A year in heart failure: an update of recent findings. ESC Heart Fail 2021;8:4370-93. [PMID: 34918477 DOI: 10.1002/ehf2.13760] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
88 Zalewski J, Nowak K, Furczynska P, Zalewska M. Complicating Acute Myocardial Infarction. Current Status and Unresolved Targets for Subsequent Research. J Clin Med 2021;10:5904. [PMID: 34945202 DOI: 10.3390/jcm10245904] [Reference Citation Analysis]
89 González-Pacheco H, Manzur-Sandoval D, Gopar-Nieto R, Álvarez-Sangabriel A, Martínez-Sánchez C, Eid-Lidt G, Altamirano-Castillo A, Mendoza-García S, Briseño-Cruz JL, Azar-Manzur F, Araiza-Garaygordobil D, Sierra-Lara D, Jiménez-Rodríguez GM, Lazcano-Díaz EA, Baranda-Tovar F, Valencia-Älvarez JS, Cutz-Ijchajchal MA, Penagos-Cordon JC, Morejon-Barragán P, Arias-Mendoza A. Cardiogenic Shock Among Patients with and without Acute Myocardial Infarction in a Latin American Country: A Single-Institution Study. Glob Heart 2021;16:78. [PMID: 34900569 DOI: 10.5334/gh.988] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
90 Tomasoni D, Adamo M, Metra M. November 2021 at a glance: focus on prevention, comorbidities, cardiogenic shock and novel devices. Eur J Heart Fail 2021;23:1803-5. [PMID: 34866292 DOI: 10.1002/ejhf.1894] [Reference Citation Analysis]
91 Task Force for the management of COVID-19 of the European Society of Cardiology . ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2-care pathways, treatment, and follow-up. Cardiovasc Res 2021:cvab343. [PMID: 34864876 DOI: 10.1093/cvr/cvab343] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
92 Task Force for the management of COVID-19 of the European Society of Cardiology . ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2-care pathways, treatment, and follow-up. Eur Heart J 2021:ehab697. [PMID: 34791154 DOI: 10.1093/eurheartj/ehab697] [Cited by in Crossref: 37] [Cited by in F6Publishing: 46] [Article Influence: 18.5] [Reference Citation Analysis]
93 Morici N, Marini C, Sacco A, Tavazzi G, Saia F, Palazzini M, Oliva F, De Ferrari GM, Colombo PC, Kapur NK, Garan AR, Pappalardo F. Intra-aortic balloon pump for acute-on-chronic heart failure complicated by cardiogenic shock. J Card Fail 2021:S1071-9164(21)00468-1. [PMID: 34774745 DOI: 10.1016/j.cardfail.2021.11.009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
94 Pérez Vela J, Llanos Jorge C, Duerto Álvarez J, Jiménez Rivera J. Manejo clínico del shock poscardiotomía en pacientes adultos. Medicina Intensiva 2021. [DOI: 10.1016/j.medin.2021.08.007] [Reference Citation Analysis]
95 Reina-Couto M, Pereira-Terra P, Quelhas-Santos J, Silva-Pereira C, Albino-Teixeira A, Sousa T. Inflammation in Human Heart Failure: Major Mediators and Therapeutic Targets. Front Physiol 2021;12:746494. [PMID: 34707513 DOI: 10.3389/fphys.2021.746494] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
96 Radu RI, Ben Gal T, Abdelhamid M, Antohi EL, Adamo M, Ambrosy AP, Geavlete O, Lopatin Y, Lyon A, Miro O, Metra M, Parissis J, Collins SP, Anker SD, Chioncel O. Antithrombotic and anticoagulation therapies in cardiogenic shock: a critical review of the published literature. ESC Heart Fail 2021. [PMID: 34664409 DOI: 10.1002/ehf2.13643] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
97 Omerovic E, Citro R, Bossone E, Redfors B, Backs J, Bruns B, Ciccarelli M, Couch LS, Dawson D, Grassi G, Iacoviello M, Parodi G, Schneider B, Templin C, Ghadri JR, Thum T, Chioncel O, Tocchetti CG, Van Der Velden J, Heymans S, Lyon AR. Pathophysiology of Takotsubo syndrome - a joint scientific statement from the Heart Failure Association Takotsubo Syndrome Study Group and Myocardial Function Working Group of the European Society of Cardiology - Part 2: vascular pathophysiology, gender and sex hormones, genetics, chronic cardiovascular problems and clinical implications. Eur J Heart Fail 2021. [PMID: 34655287 DOI: 10.1002/ejhf.2368] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
98 Abraham J, Blumer V, Burkhoff D, Pahuja M, Sinha SS, Rosner C, Vorovich E, Grafton G, Bagnola A, Hernandez-montfort JA, Kapur NK. Heart Failure-Related Cardiogenic Shock: Pathophysiology, Evaluation and Management Considerations. Journal of Cardiac Failure 2021;27:1126-40. [DOI: 10.1016/j.cardfail.2021.08.010] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 7.0] [Reference Citation Analysis]
99 Mcdonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, Burri H, Butler J, Čelutkienė J, Chioncel O, Cleland JGF, Coats AJS, Crespo-leiro MG, Farmakis D, Gilard M, Heymans S, Hoes AW, Jaarsma T, Jankowska EA, Lainscak M, Lam CSP, Lyon AR, Mcmurray JJV, Mebazaa A, Mindham R, Muneretto C, Francesco Piepoli M, Price S, Rosano GMC, Ruschitzka F, Kathrine Skibelund A, de Boer RA, Christian Schulze P, Abdelhamid M, Aboyans V, Adamopoulos S, Anker SD, Arbelo E, Asteggiano R, Bauersachs J, Bayes-genis A, Borger MA, Budts W, Cikes M, Damman K, Delgado V, Dendale P, Dilaveris P, Drexel H, Ezekowitz J, Falk V, Fauchier L, Filippatos G, Fraser A, Frey N, Gale CP, Gustafsson F, Harris J, Iung B, Janssens S, Jessup M, Konradi A, Kotecha D, Lambrinou E, Lancellotti P, Landmesser U, Leclercq C, Lewis BS, Leyva F, Linhart A, Løchen M, Lund LH, Mancini D, Masip J, Milicic D, Mueller C, Nef H, Nielsen J, Neubeck L, Noutsias M, Petersen SE, Sonia Petronio A, Ponikowski P, Prescott E, Rakisheva A, Richter DJ, Schlyakhto E, Seferovic P, Senni M, Sitges M, Sousa-uva M, Tocchetti CG, Touyz RM, Tschoepe C, Waltenberger J, Adamo M, Baumbach A, Böhm M, Burri H, Čelutkienė J, Chioncel O, Cleland JGF, Coats AJS, Crespo-leiro MG, Farmakis D, Gardner RS, Gilard M, Heymans S, Hoes AW, Jaarsma T, Jankowska EA, Lainscak M, Lam CSP, Lyon AR, Mcmurray JJV, Mebazaa A, Mindham R, Muneretto C, Piepoli MF, Price S, Rosano GMC, Ruschitzka F, Skibelund AK, ESC Scientific Document Group. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. European Heart Journal 2021;42:3599-3726. [DOI: 10.1093/eurheartj/ehab368] [Cited by in Crossref: 2535] [Article Influence: 1267.5] [Reference Citation Analysis]
100 Mcdonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, Burri H, Butler J, Čelutkienė J, Chioncel O, Cleland JGF, Coats AJS, Crespo-leiro MG, Farmakis D, Gilard M, Heymans S, Hoes AW, Jaarsma T, Jankowska EA, Lainscak M, Lam CSP, Lyon AR, Mcmurray JJV, Mebazaa A, Mindham R, Muneretto C, Francesco Piepoli M, Price S, Rosano GMC, Ruschitzka F, Kathrine Skibelund A, de Boer RA, Christian Schulze P, Abdelhamid M, Aboyans V, Adamopoulos S, Anker SD, Arbelo E, Asteggiano R, Bauersachs J, Bayes-genis A, Borger MA, Budts W, Cikes M, Damman K, Delgado V, Dendale P, Dilaveris P, Drexel H, Ezekowitz J, Falk V, Fauchier L, Filippatos G, Fraser A, Frey N, Gale CP, Gustafsson F, Harris J, Iung B, Janssens S, Jessup M, Konradi A, Kotecha D, Lambrinou E, Lancellotti P, Landmesser U, Leclercq C, Lewis BS, Leyva F, Linhart A, Løchen M, Lund LH, Mancini D, Masip J, Milicic D, Mueller C, Nef H, Nielsen J, Neubeck L, Noutsias M, Petersen SE, Sonia Petronio A, Ponikowski P, Prescott E, Rakisheva A, Richter DJ, Schlyakhto E, Seferovic P, Senni M, Sitges M, Sousa-uva M, Tocchetti CG, Touyz RM, Tschoepe C, Waltenberger J, Adamo M, Baumbach A, Böhm M, Burri H, Čelutkienė J, Chioncel O, Cleland JGF, Coats AJS, Crespo-leiro MG, Farmakis D, Gardner RS, Gilard M, Heymans S, Hoes AW, Jaarsma T, Jankowska EA, Lainscak M, Lam CSP, Lyon AR, Mcmurray JJV, Mebazaa A, Mindham R, Muneretto C, Piepoli MF, Price S, Rosano GMC, Ruschitzka F, Skibelund AK, ESC Scientific Document Group. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. European Heart Journal 2021;42:3599-3726. [DOI: 10.1093/eurheartj/ehab368] [Cited by in Crossref: 2535] [Article Influence: 1267.5] [Reference Citation Analysis]
101 Mcdonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, Burri H, Butler J, Čelutkienė J, Chioncel O, Cleland JGF, Coats AJS, Crespo-leiro MG, Farmakis D, Gilard M, Heymans S, Hoes AW, Jaarsma T, Jankowska EA, Lainscak M, Lam CSP, Lyon AR, Mcmurray JJV, Mebazaa A, Mindham R, Muneretto C, Francesco Piepoli M, Price S, Rosano GMC, Ruschitzka F, Kathrine Skibelund A, de Boer RA, Christian Schulze P, Abdelhamid M, Aboyans V, Adamopoulos S, Anker SD, Arbelo E, Asteggiano R, Bauersachs J, Bayes-genis A, Borger MA, Budts W, Cikes M, Damman K, Delgado V, Dendale P, Dilaveris P, Drexel H, Ezekowitz J, Falk V, Fauchier L, Filippatos G, Fraser A, Frey N, Gale CP, Gustafsson F, Harris J, Iung B, Janssens S, Jessup M, Konradi A, Kotecha D, Lambrinou E, Lancellotti P, Landmesser U, Leclercq C, Lewis BS, Leyva F, Linhart A, Løchen M, Lund LH, Mancini D, Masip J, Milicic D, Mueller C, Nef H, Nielsen J, Neubeck L, Noutsias M, Petersen SE, Sonia Petronio A, Ponikowski P, Prescott E, Rakisheva A, Richter DJ, Schlyakhto E, Seferovic P, Senni M, Sitges M, Sousa-uva M, Tocchetti CG, Touyz RM, Tschoepe C, Waltenberger J, Adamo M, Baumbach A, Böhm M, Burri H, Čelutkienė J, Chioncel O, Cleland JGF, Coats AJS, Crespo-leiro MG, Farmakis D, Gardner RS, Gilard M, Heymans S, Hoes AW, Jaarsma T, Jankowska EA, Lainscak M, Lam CSP, Lyon AR, Mcmurray JJV, Mebazaa A, Mindham R, Muneretto C, Piepoli MF, Price S, Rosano GMC, Ruschitzka F, Skibelund AK, ESC Scientific Document Group. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. European Heart Journal 2021;42:3599-3726. [DOI: 10.1093/eurheartj/ehab368] [Cited by in Crossref: 2535] [Article Influence: 1267.5] [Reference Citation Analysis]
102 Mcdonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, Burri H, Butler J, Čelutkienė J, Chioncel O, Cleland JGF, Coats AJS, Crespo-leiro MG, Farmakis D, Gilard M, Heymans S, Hoes AW, Jaarsma T, Jankowska EA, Lainscak M, Lam CSP, Lyon AR, Mcmurray JJV, Mebazaa A, Mindham R, Muneretto C, Francesco Piepoli M, Price S, Rosano GMC, Ruschitzka F, Kathrine Skibelund A, de Boer RA, Christian Schulze P, Abdelhamid M, Aboyans V, Adamopoulos S, Anker SD, Arbelo E, Asteggiano R, Bauersachs J, Bayes-genis A, Borger MA, Budts W, Cikes M, Damman K, Delgado V, Dendale P, Dilaveris P, Drexel H, Ezekowitz J, Falk V, Fauchier L, Filippatos G, Fraser A, Frey N, Gale CP, Gustafsson F, Harris J, Iung B, Janssens S, Jessup M, Konradi A, Kotecha D, Lambrinou E, Lancellotti P, Landmesser U, Leclercq C, Lewis BS, Leyva F, Linhart A, Løchen M, Lund LH, Mancini D, Masip J, Milicic D, Mueller C, Nef H, Nielsen J, Neubeck L, Noutsias M, Petersen SE, Sonia Petronio A, Ponikowski P, Prescott E, Rakisheva A, Richter DJ, Schlyakhto E, Seferovic P, Senni M, Sitges M, Sousa-uva M, Tocchetti CG, Touyz RM, Tschoepe C, Waltenberger J, Adamo M, Baumbach A, Böhm M, Burri H, Čelutkienė J, Chioncel O, Cleland JGF, Coats AJS, Crespo-leiro MG, Farmakis D, Gardner RS, Gilard M, Heymans S, Hoes AW, Jaarsma T, Jankowska EA, Lainscak M, Lam CSP, Lyon AR, Mcmurray JJV, Mebazaa A, Mindham R, Muneretto C, Piepoli MF, Price S, Rosano GMC, Ruschitzka F, Skibelund AK, ESC Scientific Document Group. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. European Heart Journal 2021;42:3599-3726. [DOI: 10.1093/eurheartj/ehab368] [Cited by in Crossref: 2535] [Article Influence: 1267.5] [Reference Citation Analysis]
103 McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, Burri H, Butler J, Čelutkienė J, Chioncel O, Cleland JGF, Coats AJS, Crespo-Leiro MG, Farmakis D, Gilard M, Heymans S, Hoes AW, Jaarsma T, Jankowska EA, Lainscak M, Lam CSP, Lyon AR, McMurray JJV, Mebazaa A, Mindham R, Muneretto C, Francesco Piepoli M, Price S, Rosano GMC, Ruschitzka F, Kathrine Skibelund A; ESC Scientific Document Group. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 2021;42:3599-726. [PMID: 34447992 DOI: 10.1093/eurheartj/ehab368] [Cited by in Crossref: 1638] [Cited by in F6Publishing: 1880] [Article Influence: 819.0] [Reference Citation Analysis]
104 Mcdonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, Burri H, Butler J, Čelutkienė J, Chioncel O, Cleland JGF, Coats AJS, Crespo-leiro MG, Farmakis D, Gilard M, Heymans S, Hoes AW, Jaarsma T, Jankowska EA, Lainscak M, Lam CSP, Lyon AR, Mcmurray JJV, Mebazaa A, Mindham R, Muneretto C, Francesco Piepoli M, Price S, Rosano GMC, Ruschitzka F, Kathrine Skibelund A, de Boer RA, Christian Schulze P, Abdelhamid M, Aboyans V, Adamopoulos S, Anker SD, Arbelo E, Asteggiano R, Bauersachs J, Bayes-genis A, Borger MA, Budts W, Cikes M, Damman K, Delgado V, Dendale P, Dilaveris P, Drexel H, Ezekowitz J, Falk V, Fauchier L, Filippatos G, Fraser A, Frey N, Gale CP, Gustafsson F, Harris J, Iung B, Janssens S, Jessup M, Konradi A, Kotecha D, Lambrinou E, Lancellotti P, Landmesser U, Leclercq C, Lewis BS, Leyva F, Linhart A, Løchen M, Lund LH, Mancini D, Masip J, Milicic D, Mueller C, Nef H, Nielsen J, Neubeck L, Noutsias M, Petersen SE, Sonia Petronio A, Ponikowski P, Prescott E, Rakisheva A, Richter DJ, Schlyakhto E, Seferovic P, Senni M, Sitges M, Sousa-uva M, Tocchetti CG, Touyz RM, Tschoepe C, Waltenberger J, Adamo M, Baumbach A, Böhm M, Burri H, Čelutkienė J, Chioncel O, Cleland JGF, Coats AJS, Crespo-leiro MG, Farmakis D, Gardner RS, Gilard M, Heymans S, Hoes AW, Jaarsma T, Jankowska EA, Lainscak M, Lam CSP, Lyon AR, Mcmurray JJV, Mebazaa A, Mindham R, Muneretto C, Piepoli MF, Price S, Rosano GMC, Ruschitzka F, Skibelund AK, ESC Scientific Document Group. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. European Heart Journal 2021;42:3599-3726. [DOI: 10.1093/eurheartj/ehab368] [Cited by in Crossref: 2535] [Article Influence: 1267.5] [Reference Citation Analysis]
105 Mcdonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, Burri H, Butler J, Čelutkienė J, Chioncel O, Cleland JGF, Coats AJS, Crespo-leiro MG, Farmakis D, Gilard M, Heymans S, Hoes AW, Jaarsma T, Jankowska EA, Lainscak M, Lam CSP, Lyon AR, Mcmurray JJV, Mebazaa A, Mindham R, Muneretto C, Francesco Piepoli M, Price S, Rosano GMC, Ruschitzka F, Kathrine Skibelund A, de Boer RA, Christian Schulze P, Abdelhamid M, Aboyans V, Adamopoulos S, Anker SD, Arbelo E, Asteggiano R, Bauersachs J, Bayes-genis A, Borger MA, Budts W, Cikes M, Damman K, Delgado V, Dendale P, Dilaveris P, Drexel H, Ezekowitz J, Falk V, Fauchier L, Filippatos G, Fraser A, Frey N, Gale CP, Gustafsson F, Harris J, Iung B, Janssens S, Jessup M, Konradi A, Kotecha D, Lambrinou E, Lancellotti P, Landmesser U, Leclercq C, Lewis BS, Leyva F, Linhart A, Løchen M, Lund LH, Mancini D, Masip J, Milicic D, Mueller C, Nef H, Nielsen J, Neubeck L, Noutsias M, Petersen SE, Sonia Petronio A, Ponikowski P, Prescott E, Rakisheva A, Richter DJ, Schlyakhto E, Seferovic P, Senni M, Sitges M, Sousa-uva M, Tocchetti CG, Touyz RM, Tschoepe C, Waltenberger J, Adamo M, Baumbach A, Böhm M, Burri H, Čelutkienė J, Chioncel O, Cleland JGF, Coats AJS, Crespo-leiro MG, Farmakis D, Gardner RS, Gilard M, Heymans S, Hoes AW, Jaarsma T, Jankowska EA, Lainscak M, Lam CSP, Lyon AR, Mcmurray JJV, Mebazaa A, Mindham R, Muneretto C, Piepoli MF, Price S, Rosano GMC, Ruschitzka F, Skibelund AK, ESC Scientific Document Group. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. European Heart Journal 2021;42:3599-3726. [DOI: 10.1093/eurheartj/ehab368] [Cited by in Crossref: 2535] [Article Influence: 1267.5] [Reference Citation Analysis]
106 Mcdonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, Burri H, Butler J, Čelutkienė J, Chioncel O, Cleland JGF, Coats AJS, Crespo-leiro MG, Farmakis D, Gilard M, Heymans S, Hoes AW, Jaarsma T, Jankowska EA, Lainscak M, Lam CSP, Lyon AR, Mcmurray JJV, Mebazaa A, Mindham R, Muneretto C, Francesco Piepoli M, Price S, Rosano GMC, Ruschitzka F, Kathrine Skibelund A, de Boer RA, Christian Schulze P, Abdelhamid M, Aboyans V, Adamopoulos S, Anker SD, Arbelo E, Asteggiano R, Bauersachs J, Bayes-genis A, Borger MA, Budts W, Cikes M, Damman K, Delgado V, Dendale P, Dilaveris P, Drexel H, Ezekowitz J, Falk V, Fauchier L, Filippatos G, Fraser A, Frey N, Gale CP, Gustafsson F, Harris J, Iung B, Janssens S, Jessup M, Konradi A, Kotecha D, Lambrinou E, Lancellotti P, Landmesser U, Leclercq C, Lewis BS, Leyva F, Linhart A, Løchen M, Lund LH, Mancini D, Masip J, Milicic D, Mueller C, Nef H, Nielsen J, Neubeck L, Noutsias M, Petersen SE, Sonia Petronio A, Ponikowski P, Prescott E, Rakisheva A, Richter DJ, Schlyakhto E, Seferovic P, Senni M, Sitges M, Sousa-uva M, Tocchetti CG, Touyz RM, Tschoepe C, Waltenberger J, Adamo M, Baumbach A, Böhm M, Burri H, Čelutkienė J, Chioncel O, Cleland JGF, Coats AJS, Crespo-leiro MG, Farmakis D, Gardner RS, Gilard M, Heymans S, Hoes AW, Jaarsma T, Jankowska EA, Lainscak M, Lam CSP, Lyon AR, Mcmurray JJV, Mebazaa A, Mindham R, Muneretto C, Piepoli MF, Price S, Rosano GMC, Ruschitzka F, Skibelund AK, ESC Scientific Document Group. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. European Heart Journal 2021;42:3599-3726. [DOI: 10.1093/eurheartj/ehab368] [Cited by in Crossref: 2535] [Article Influence: 1267.5] [Reference Citation Analysis]
107 Pazdernik M, Gramegna M, Bohm A, Trepa M, Vandenbriele C, De Rosa S, Uzokov J, Aleksic M, Jarakovic M, El Tahlawi M, Mostafa M, Stratinaki M, Araiza-Garaygordobil D, Gubareva E, Duplyakova P, Chacon-Diaz M, Refaat H, Guerra F, Cappelletti AM, Berka V, Westermann D, Schrage B. Regional differences in presentation characteristics, use of treatments and outcome of patients with cardiogenic shock: Results from multicenter, international registry. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2021;165:291-7. [PMID: 34421120 DOI: 10.5507/bp.2021.046] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
108 Parlow S, Di Santo P, Mathew R, Jung RG, Simard T, Gillmore T, Mao B, Abdel-Razek O, Ramirez FD, Marbach JA, Dick A, Glover C, Russo JJ, Froeschl M, Labinaz M, Fernando SM, Hibbert B. The association between mean arterial pressure and outcomes in patients with cardiogenic shock: insights from the DOREMI trial. Eur Heart J Acute Cardiovasc Care 2021:zuab052. [PMID: 34382063 DOI: 10.1093/ehjacc/zuab052] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
109 Chioncel O, Metra M. Cardiogenic shock centres for optimal care coordination and improving outcomes in cardiogenic shock. Eur J Heart Fail 2021. [PMID: 34350683 DOI: 10.1002/ejhf.2320] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
110 Conti N, Gatti M, Raschi E, Diemberger I, Potena L. Evidence and Current Use of Levosimendan in the Treatment of Heart Failure: Filling the Gap. Drug Des Devel Ther 2021;15:3391-409. [PMID: 34376973 DOI: 10.2147/DDDT.S295214] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
111 Jentzer JC, Tabi M, Burstein B. Managing the first 120 min of cardiogenic shock: from resuscitation to diagnosis. Curr Opin Crit Care 2021;27:416-25. [PMID: 33967208 DOI: 10.1097/MCC.0000000000000839] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
112 VanDyck TJ, Pinsky MR. Hemodynamic monitoring in cardiogenic shock. Curr Opin Crit Care 2021;27:454-9. [PMID: 33967209 DOI: 10.1097/MCC.0000000000000838] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
113 De Backer D, Arias Ortiz J, Levy B. The medical treatment of cardiogenic shock: cardiovascular drugs. Curr Opin Crit Care 2021;27:426-32. [PMID: 33797431 DOI: 10.1097/MCC.0000000000000822] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
114 Josiassen J, Møller JE, Holmvang L, Hassager C. Interventional treatment of acute myocardial infarction-related cardiogenic shock. Curr Opin Crit Care 2021;27:433-9. [PMID: 33929343 DOI: 10.1097/MCC.0000000000000835] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
115 Bertini P, Guarracino F. Pathophysiology of cardiogenic shock. Curr Opin Crit Care 2021;27:409-15. [PMID: 34039874 DOI: 10.1097/MCC.0000000000000853] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
116 Tsangaris A, Alexy T, Kalra R, Kosmopoulos M, Elliott A, Bartos JA, Yannopoulos D. Overview of Veno-Arterial Extracorporeal Membrane Oxygenation (VA-ECMO) Support for the Management of Cardiogenic Shock. Front Cardiovasc Med 2021;8:686558. [PMID: 34307500 DOI: 10.3389/fcvm.2021.686558] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
117 Pagnesi M, Adamo M, Metra M. March 2021 at a glance: focus on epidemiology, prevention and COVID-19. Eur J Heart Fail 2021;23:347-9. [PMID: 33915003 DOI: 10.1002/ejhf.1878] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
118 Tehrani BN, Truesdell AG, Psotka MA, Rosner C, Singh R, Sinha SS, Damluji AA, Batchelor WB. A Standardized and Comprehensive Approach to the Management of Cardiogenic Shock. JACC Heart Fail 2020;8:879-91. [PMID: 33121700 DOI: 10.1016/j.jchf.2020.09.005] [Cited by in Crossref: 63] [Cited by in F6Publishing: 51] [Article Influence: 31.5] [Reference Citation Analysis]
119 Lu DY, Adelsheimer A, Chan K, Yeo I, Krishnan U, Karas MG, Horn EM, Feldman DN, Sobol I, Goyal P, Bhatt R, Batra S, Sciria CT, Olonoff D, Cheung JW, Kim LK. Impact of hospital transfer to hubs on outcomes of cardiogenic shock in the real world. Eur J Heart Fail 2021. [PMID: 34114302 DOI: 10.1002/ejhf.2263] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
120 Morici N, Viola G, Antolini L, Alicandro G, Dal Martello M, Sacco A, Bottiroli M, Pappalardo F, Villanova L, De Ponti L, La Vecchia C, Frigerio M, Oliva F, Fried J, Colombo P, Garan AR. Predicting survival in patients with acute decompensated heart failure complicated by cardiogenic shock. Int J Cardiol Heart Vasc 2021;34:100809. [PMID: 34141863 DOI: 10.1016/j.ijcha.2021.100809] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
121 Bueno H, Moura B, Lancellotti P, Bauersachs J. The year in cardiovascular medicine 2020: heart failure and cardiomyopathies. Eur Heart J. 2021;42:657-670. [PMID: 33388764 DOI: 10.1093/eurheartj/ehaa1061] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
122 Hernandez-Montfort J, Sinha SS, Thayer KL, Whitehead EH, Pahuja M, Garan AR, Mahr C, Haywood JL, Harwani NM, Schaeffer A, Wencker D, Kanwar M, Vorovich E, Abraham J, Burkhoff D, Kapur NK. Clinical Outcomes Associated With Acute Mechanical Circulatory Support Utilization in Heart Failure Related Cardiogenic Shock. Circ Heart Fail 2021;14:e007924. [PMID: 33905259 DOI: 10.1161/CIRCHEARTFAILURE.120.007924] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 9.5] [Reference Citation Analysis]
123 Bertoldi LF, Montisci A, Delmas C, Pappalardo F. Weaning from Impella and mobilization of Impella patients. Eur Heart J Suppl 2021;23:A41-5. [PMID: 33815014 DOI: 10.1093/eurheartj/suab008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
124 Tarantini G, Masiero G, Burzotta F, Pazzanese V, Briguori C, Trani C, Piva T, De Marco F, Di Biasi M, Pagnotta P, Mojoli M, Casu G, Giustino G, Lorenzoni G, Montorfano M, Ancona MB, Pappalardo F, Chieffo A; IMPella Mechanical Circulatory Support Device in Italy (IMP-IT) Registry authors. Timing of Impella implantation and outcomes in cardiogenic shock or high-risk percutaneous coronary revascularization. Catheter Cardiovasc Interv 2021;98:E222-34. [PMID: 33793051 DOI: 10.1002/ccd.29674] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
125 Bueno H, Moura B, Lancellotti P, Bauersachs J. The year in cardiovascular medicine 2020: heart failure and cardiomyopathies. Cardiologia Croatica 2021;16:140-156. [DOI: 10.15836/ccar2021.140] [Reference Citation Analysis]
126 Chioncel O, Coats AJS. National Heart Failure Societies Summit 2020. Eur J Heart Fail 2021;23:507-10. [PMID: 33749046 DOI: 10.1002/ejhf.2157] [Reference Citation Analysis]
127 . Corrigendum to 'Epidemiology, pathophysiology and contemporary management of cardiogenic shock - a position statement from the Heart Failure Association of the European Society of Cardiology' [Eur J Heart Fail 2020;22:1315-1341]. Eur J Heart Fail 2021;23:345. [PMID: 33783084 DOI: 10.1002/ejhf.2152] [Reference Citation Analysis]
128 Farmakis D, Polyzogopoulou E, Parissis J. Extracorporeal life support at the emergency department: new insights into the management of acute cardiac care patients. Hellenic J Cardiol 2021;62:46-7. [PMID: 33753233 DOI: 10.1016/j.hjc.2021.03.001] [Reference Citation Analysis]
129 Arrigo M, Huber LC. Pulmonary Embolism and Heart Failure: A Reappraisal. Card Fail Rev 2020;7:e03. [PMID: 33708418 DOI: 10.15420/cfr.2020.26] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
130 Kimmoun A, Duarte K, Harjola VP, Tarvasmäki T, Levy B, Mebazaa A, Gibot S; CardShock Investigators and the GREAT network. Soluble triggering receptor expressed on myeloid cells-1 is a marker of organ injuries in cardiogenic shock: results from the CardShock Study. Clin Res Cardiol 2021. [PMID: 33677708 DOI: 10.1007/s00392-021-01823-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
131 Morici N, Marini C, Sacco A, Tavazzi G, Cipriani M, Oliva F, Rota M, De Ferrari GM, Campolo J, Frigerio G, Valente S, Leonardi S, Corrada E, Bottiroli M, Grosseto D, Cacciavillani L, Frigerio M, Pappalardo F; Altshock-2 Group. Early intra-aortic balloon pump in acute decompensated heart failure complicated by cardiogenic shock: Rationale and design of the randomized Altshock-2 trial. Am Heart J 2021;233:39-47. [PMID: 33338464 DOI: 10.1016/j.ahj.2020.11.017] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
132 Balthazar T, Vandenbriele C, Verbrugge FH, Den Uil C, Engström A, Janssens S, Rex S, Meyns B, Van Mieghem N, Price S, Adriaenssens T. Managing Patients With Short-Term Mechanical Circulatory Support: JACC Review Topic of the Week. J Am Coll Cardiol 2021;77:1243-56. [PMID: 33663742 DOI: 10.1016/j.jacc.2020.12.054] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
133 Marcondes-Braga FG, Vieira JL, Souza Neto JD, Calado G, Ayub-Ferreira SM, Bacal F, Clausell N. Emerging Topics in Heart Failure: Contemporaneous Management of Advanced Heart Failure. Arq Bras Cardiol 2020;115:1193-6. [PMID: 33470324 DOI: 10.36660/abc.20201194] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
134 Pappalardo F, Malara G, Montisci A. Multitarget Approach to Cardiogenic Shock after Acute Myocardial Infarction: Extracorporeal Life Support (ECLS) and Beyond. Membranes (Basel) 2021;11:87. [PMID: 33513892 DOI: 10.3390/membranes11020087] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
135 Jentzer JC, Burstein B, Van Diepen S, Murphy J, Holmes DR Jr, Bell MR, Barsness GW, Henry TD, Menon V, Rihal CS, Naidu SS, Baran DA. Defining Shock and Preshock for Mortality Risk Stratification in Cardiac Intensive Care Unit Patients. Circ Heart Fail 2021;14:e007678. [PMID: 33464952 DOI: 10.1161/CIRCHEARTFAILURE.120.007678] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
136 Gupta AK, Tomasoni D, Sidhu K, Metra M, Ezekowitz JA. Evidence-Based Management of Acute Heart Failure. Can J Cardiol 2021;37:621-31. [PMID: 33440229 DOI: 10.1016/j.cjca.2021.01.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
137 Scudiero F, Silverio A, Di Maio M, Russo V, Citro R, Personeni D, Cafro A, D'Andrea A, Attena E, Pezzullo S, Canonico ME, Galasso G, Pitì A, Parodi G; Cov-IT Network. Pulmonary embolism in COVID-19 patients: prevalence, predictors and clinical outcome. Thromb Res 2021;198:34-9. [PMID: 33271421 DOI: 10.1016/j.thromres.2020.11.017] [Cited by in Crossref: 43] [Cited by in F6Publishing: 50] [Article Influence: 14.3] [Reference Citation Analysis]
138 González-Pacheco H, Álvarez-Sangabriel A, Martínez-Sánchez C, Briseño-Cruz JL, Altamirano-Castillo A, Mendoza-García S, Manzur-Sandoval D, Amezcua-Guerra LM, Sandoval J, Bojalil R, Araiza-Garaygordobil D, Sierra-Lara D, Guiza-Sánchez CA, Gopar-Nieto R, Cruz-Rodríguez C, Valdivia-Nuño JJ, Salas-Teles B, Arias-Mendoza A. Clinical phenotypes, aetiologies, management, and mortality in acute heart failure: a single-institution study in Latin-America. ESC Heart Fail 2021;8:423-37. [PMID: 33179453 DOI: 10.1002/ehf2.13092] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
139 Uhlig K, Efremov L, Tongers J, Frantz S, Mikolajczyk R, Sedding D, Schumann J. Inotropic agents and vasodilator strategies for the treatment of cardiogenic shock or low cardiac output syndrome. Cochrane Database Syst Rev 2020;11:CD009669. [PMID: 33152122 DOI: 10.1002/14651858.CD009669.pub4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
140 Cormican DS, Sonny A, Crowley J, Sheu R, Sun T, Gibson CM, Núñez-Gil IJ, Ramakrishna H. Acute Myocardial Infarction Complicated by Cardiogenic Shock: Analysis of the Position Statement From the European Society of Cardiology Acute Cardiovascular Care Association, With Perioperative Implications. J Cardiothorac Vasc Anesth 2021;35:3098-104. [PMID: 33234469 DOI: 10.1053/j.jvca.2020.10.062] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
141 Shabana A, Dholoo F, Banerjee P. Inotropic Agents and Vasopressors in the Treatment of Cardiogenic Shock. Curr Heart Fail Rep 2020;17:438-48. [PMID: 33103204 DOI: 10.1007/s11897-020-00493-9] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
142 Zhang X, Guo T, Zhang K, Guo W, An X, Gao P. Effect of shenfu injection on microcirculation in shock patients: A protocol for systematic review and meta-analysis. Medicine (Baltimore) 2020;99:e22872. [PMID: 33120828 DOI: 10.1097/MD.0000000000022872] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
143 Zhou R, Wang L, Zhao G, Chen D, Song X, Momtazi-Borojeni AA, Yuan H. Circulating exosomal microRNAs as emerging non-invasive clinical biomarkers in heart failure: Mega bio-roles of a nano bio-particle. IUBMB Life 2020;72:2546-62. [PMID: 33053610 DOI: 10.1002/iub.2396] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 6.0] [Reference Citation Analysis]
144 Josiassen J, Helgestad OKL, Møller JE, Schmidt H, Jensen LO, Holmvang L, Ravn HB, Hassager C. Cardiogenic shock due to predominantly right ventricular failure complicating acute myocardial infarction. Eur Heart J Acute Cardiovasc Care 2021;10:33-9. [PMID: 33620420 DOI: 10.1093/ehjacc/zuaa010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
145 Chioncel O, Collins SP, Seferovic P. Does end-organ dysfunction precede or follow cardiogenic shock in acute decompensated heart failure? The two-faced Janus. Reply. Eur J Heart Fail 2021;23:197-8. [PMID: 32667101 DOI: 10.1002/ejhf.1965] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
146 Angelini F, Bocchino PP, Frea S, De Ferrari GM. Does end-organ dysfunction precede or follow cardiogenic shock in acute decompensated heart failure? The two-faced Janus. Letter regarding the article 'Epidemiology, pathophysiology and contemporary management of cardiogenic shock - a position statement from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)'. Eur J Heart Fail 2021;23:197. [PMID: 32572990 DOI: 10.1002/ejhf.1940] [Reference Citation Analysis]